Biotech

Otonomy Inc (NASDAQ:OTIC) shares rose 17.71% to $13.76 on Friday, following reports that the company was granted approval for its pass-through payments. On May 20, Otonomy Inc (NASDAQ:OTIC) announced that the Centers for Medicare and Medicaid Services (CMS) has approved transitional pass-through status. In addition, CMS established a new billing code for...

Celator Pharmaceuticals Inc (NASDAQ:CPXX) shares rose 8.62% to $15.38 on Tuesday, edging close to the top of its yearly range at $17.40. Celator Pharmaceuticals Inc (NASDAQ:CPXX) could be prime for a selloff on profit-taking, as investors might be waiting to close their bullish positions on the stock around the top...

Cytori Therapeutics Inc (NASDAQ:CYTX) shares advanced 35.92% to $3.33 on Tuesday after the company announced that it would present an update on their clinical trials during the 104th Annual Meeting of the Japan Society of Aesthetic Surgery in Tokyo, Japan. Cytori Therapeutics Inc (NASDAQ:CYTX) shares retreated 3.90% to $3.20 in after-hours...

Coherus Biosciences Inc (NASDAQ:CHRS) shares advanced 15.58% to $18.85 on Tuesday following a favorable decision from the US Patent and Trademark Office for '135 IPR. Coherus Biosciences Inc (NASDAQ:CHRS) is a late-stage clinical biologics platform company focused on the global biosimilar market. The company develops and commercializes biosimilar products segment organized around therapeutic franchises. The...

Vitae Pharmaceuticals Inc (NASDAQ:VTAE) shares were up 17.06% to $7.48 on Monday even after the company reported a loss for the first quarter of the year. Vitae Pharmaceuticals Inc (NASDAQ:VTAE) is a biotechnology company focused on  discovering and developing small molecule drugs for diseases. In particular, the company is engaged in developing a portfolio...